Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hubbard, A. K.
Right arrow Articles by Mossman, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hubbard, A. K.
Right arrow Articles by Mossman, B. T.
(Chest. 2001;120:S24-S25.)
© 2001 American College of Chest Physicians

Use of Transgenic Luciferase Reporter Mice To Determine Activation of Transcription Factors and Gene Expression by Fibrogenic Particles*

Andrea K. Hubbard, PhD; Cynthia R. Timblin, PhD; Mercedes Rincon, PhD and Brooke T. Mossman, PhD

* From the Department of Pharmaceutical Sciences (Dr. Hubbard), University of Connecticut, Storrs, CT; and the Departments of Pathology (Drs. Timblin and Mossman) and Medicine (Dr. Rincon), University of Vermont, Burlington, VT.

Correspondence to: Brooke T. Mossman, PhD, Department of Pathology, A-145 Medical Alumni Building, University of Vermont College of Medicine, Burlington, VT 05405; e-mail: bmossman{at}zoo.uvm.edu

Exposure to silica or asbestos elicits a striking inflammatory response that is characterized by the influx of inflammatory cells, increased expression of inflammatory cytokines, cell injury, and compensatory cell proliferation.1 The regulation of these events may be dependent on the activation of transcription factors such as nuclear factor-{kappa}B (NF-{kappa}B) and/or activator protein-1 (AP-1) since the promoter regions of many genes involved in inflammation, proliferation, and/or apoptosis are known to contain binding sites for these transcription factors.2 3 Previous work from this laboratory has demonstrated increased AP-1 binding to DNA and AP-1-dependent gene transcription in mesothelial cells and tracheal epithelial cells after exposure to asbestos in vitro.4 5 We and others6 7 also have shown that asbestos causes NF-{kappa}B activation in these cell types in vitro and in an inhalation model of asbestosis. However, whether silica causes transcriptional activation of NF-{kappa}B and AP-1-dependent gene expression in the lung after exposures in vivo is unclear.

Materials and Methods

We addressed this question using intratracheal instillation of {alpha}-quartz silica (Minusil at 1 or 2 mg in phosphate-buffered saline solution) into NF-[{kappa}]B)8 (1 mg per mouse) and AP-19 (2 mg per mouse) luciferase reporter mice back-crossed into the C57/BL6 strain. Control animals received phosphate-buffered saline solution alone or fine TiO2 (obtained from Dr. Gunter Oberdorster, University of Rochester), as a nonfibrogenic particle. At time points from 4 to 72 h, mice underwent BAL for total and differential cell counts and luciferase activity. In addition, whole-lung homogenates were evaluated for luciferase activity and messenger RNA levels of fos/jun family members (AP-1 mice) and cytokine genes (NF-{kappa}B) using a ribonuclease protection assay (RPA) according to the manufacturer’s instructions (Pharmingen; San Diego, CA). Lung sections were also evaluated for luciferase protein as detected by immunocytochemistry.3 In additional experiments, AP-1 luciferase reporter mice were exposed by inhalation to silica (70 mg/m3) or crocidolite asbestos (National Institute for Environmental Health Sciences reference sample; 8.5 mg/m3) for 72 h.

Results and Conclusions

The instillation of silica particles into either NF-[{kappa}]B or AP-1 luciferase reporter mice elicited significant increases in inflammatory cells in BAL fluid and elevations in proportions of neutrophils, occurring as early as 4 h after instillation and remaining elevated for 72 h. Instillation of the positive controls, lipopolysaccharide (2 µg per mouse) (NF-{kappa}B mice), or phorbol myristate acetate (PMA) (2 µg per mouse) (AP-1 mice) also elicited significant cellular inflammation at these times.

The analysis of lung homogenates or BAL cells for luciferase activity did not reveal significant increases by silica. However, when luciferase expression was examined by immunohistochemistry, both strains of mice demonstrated increased luciferase protein in both bronchiolar epithelial cells and alveolar macrophages (AMs) in response to silica. Peak luciferase immunoreactivity occurred at 24 h after instillation. This response appeared to be specific for fibrogenic particles, since exposure to TiO2 (1 mg/mL) did not elicit increases in luciferase immunoreactivity in NF-{kappa}B reporter mice, and we have shown previously3 that luciferase protein is increased in the alveolar epithelium of AP-1 mice inhaling asbestos. In studies herein, the instillation of the positive controls, lipopolysaccharide (NF-{kappa}B mice), or PMA (AP-1 mice) also elicited marked luciferase expression in AMs and epithelial cells.

To determine whether increased luciferase immunoreactivity preceded alterations in steady-state messenger RNA levels of fos/jun family members that comprise the AP-1 transcription factor, RPA was performed at 72 h on the lungs of AP-1 mice exposed to silica by intratracheal instillation (Fig 1 , top, A) or inhalation (Fig 1 , bottom, B). Interestingly, the instillation or inhalation of silica particles elicited a significant decrease (p < 0.05 by analysis of variance) in messenger RNA levels of c-jun, whereas levels of other family members (ie, junB, junD, c-fos, fra-1, fra-2, or fosB) were unchanged in comparison to sham control mice. Mice exposed to PMA (instillation) also showed a decrease in c-jun messenger RNA. Further studies are needed to determine whether decreases in c-jun messenger RNA reflect compensatory decreases in c-jun protein in epithelial cells.



View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1. Quantitation by phosphoimaging of steady-state messenger RNA levels of c-jun in RPAs from mouse lungs exposed to silica by intratracheal instillation (top, A) or inhalation (bottom, B) for 72 h. * = p < 0.05 in comparison to sham group.

 
To determine the functional significance of NF-[{kappa}]B activation, messenger RNA levels of several cytokines the promoter regions of which are known to contain binding sites for NF-{kappa}B were measured by RPA at 4, 24, and 72 h. The instillation of silica particles elicited a significant increase in steady-state messenger RNA levels of several inflammatory cytokines (iNOS, MIP-2, MCP-1, interferon [ IFN]-{gamma}, interleukin [ IL]-1, IL-2, and IL-6) as early as 4 h after instillation. Significant increases in specific messenger RNA species also were seen at 24 h (TNF-{alpha}, iNOS, MIP-2, MCP-1, IFN-{gamma}) and 72 h (IFN-{gamma}) after instillation. Increases in MCP-1 messenger RNA levels by silica were very striking and were accompanied by increases in immunoreactivity of MCP-1 protein in AMs and alveolar type II epithelial cells (manuscript in preparation).

Our results suggest that silica initiates inflammation and epithelial cell alterations through the activation of multiple transcription factors in vivo, which in turn may govern critical events (ie, cell injury, proliferation, and increased expression of inflammatory cytokines) in fibrogenesis.

Footnotes

Abbreviations: AM = alveolar macrophage; AP-1 = activator protein-1; IFN = interferon; IL = interleukin; iNOS = inducible nitric oxide synthase; MCP = monocyte chemotactic protein; NF-{kappa}B = nuclear factor-{kappa}B; PMA = phorbol myristate acetate; RPA = ribonuclease protection assay;

Supported by National Institutes of Health grants HL39469 and ES/HL09213.

References

  1. Mossman, BT, Churg, A (1998) Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 157,1666-1680[Free Full Text]
  2. Blackwell, TS, Christman, JW (1997) The role of nuclear factor-{kappa}B in cytokine gene regulation. Am J Respir Cell Mol Biol 17,3-9[Abstract/Free Full Text]
  3. Mossman, BT, Hubbard, A, Shukla, A, et al (2000) Role of mitogen-activated protein kinases, early response protooncogenes, and activator protein-1 in cell signaling by asbestos. Inhal Toxicol 12,307-316[CrossRef]
  4. Heintz, N, Janssen, YMW, Mossman, BT (1993) Persistent induction of c-fos and c-jun expression by asbestos. Proc Natl Acad Sci U S A 90,3299-3303[Abstract/Free Full Text]
  5. Timblin, CR, Janssen, YMW, Mossman, BT (1995) Transcriptional activation of the proto-oncogene, c-jun, by asbestos and H2O2 is directly related to increased proliferation and transformation of tracheal epithelial cells. Cancer Res 55,2723-2726[Abstract/Free Full Text]
  6. Janssen, YMW, Barchowsky, A, Treadwell, M, et al (1995) Asbestos induces nuclear factor {kappa}B (NF-{kappa}B) DNA binding activity and NF-{kappa}B dependent gene expression in tracheal epithelial cells. Proc Natl Acad Sci U S A 92,8458-8462[Abstract/Free Full Text]
  7. Janssen, YMW, Driscoll, KE, Howard, B, et al (1997) Asbestos causes translocation of p65 protein and increases NF-[{kappa}]B DNA binding activity in rat lung epithelial and pleural mesothelial cells. Am J Pathol 151,389-401[Abstract]
  8. Millet, I, Phillips, R, Sherwin, RS, et al (2000) Inhibition of NF-[{kappa}]B activity and enhancement of apoptosis by the neuropeptide calcitonin gene-related peptide. J Biol Chem 257,15114-15121[CrossRef]
  9. Rincon, M, Flavell, RA (1994) AP-1 transcriptional activity requires both T cell receptor mediated and co-stimulatory signals in primary T lymphocytes. EMBO J 13,4370-4381[ISI][Medline]




This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hubbard, A. K.
Right arrow Articles by Mossman, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hubbard, A. K.
Right arrow Articles by Mossman, B. T.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS